已收盤 08-29 16:00:00 美东时间
+0.435
+6.23%
The latest update is out from NeOnc Technologies Holdings, Inc. ( ($NTHI) ). On...
08-23 05:32
NeOnc Technologies Holdings press release (NASDAQ:NTHI): Q2 GAAP EPS of $0.30. G&A expenses: $984K vs. $290K in Q2 2024, reflecting expanded marketing, rent, travel, and Middle East partnership-relate...
08-20 03:35
NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.30) per share. This is a 11.11 percent decrease over losses of $(0.27) per share from the same period last year.
08-19 21:22
NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) reported its Q2 2025 financial results and highlighted recent achievements. Key points include securing a $50 million partnership with Quazar Investment, securing $2.5 million in NIH grants, acquiring advanced AI and quantum modeling IP, and expanding its clinical trials. The company also joined the Russell Microcap Index, appointed Dr. Josh Neman as CCO, and advanced its pipeline with Phase 2 tria...
08-19 13:00
NeOnc Technologies and Quazar Investment announced the incorporation of NuroMENA Holdings Ltd. in Abu Dhabi, finalizing a $50 million investment led by Quazar to support NeOnc’s CNS cancer therapies in the MENA region. This collaboration aims to accelerate clinical programs NEO212 and NEO100, marking a pivotal step for NeOnc and Quazar in advancing innovative treatments for brain cancer and CNS disorders across the Middle East and North Africa.
08-11 13:00
<p>NeOnc Technologies Holdings, Inc. announced the award of two NIH STTR grants totaling $2.5 million to advance the development of NEO212, a therapeutic compound in Phase 1 clinical trials. The grants include a $400,000 Phase 1 grant for AML studies led by Dr. Thomas Chen and Dr. Axel Schönthal, and a $2.1 million Phase 2 grant focused on gliomas led by Dr. Chen and Dr. Radu Minea. These funds highlight NEO212's potential and NeOnc's collaborati...
08-07 13:00
NeOnc Technologies Holdings, Inc. (NTHI) featured on Yahoo Finance’s *Trader Talk* podcast, discussing its challenges and achievements, including securing a $50 million partnership and joining the Russell Microcap Index. The company focuses on intranasal drug delivery for brain cancer, leveraging AI and quantum computing for innovation. Its NEO100 and NEO212 therapeutics are in Phase II clinical trials with FDA Fast-Track status.
08-04 13:00
NeOnc Technologies Holdings, Inc. ( ($NTHI) ) has shared an update. On July 24,...
07-31 05:40
NeOnc Technologies Holdings has signed a definitive agreement to acquire a company specializing in 3D bioprinting, AI, and quantum modeling for brain cancer drug discovery. The $3.5 million deal includes cash and stock, with Dr. Ishwar Puri, a leading research scientist, joining NeOnc's board. This acquisition aims to accelerate drug development and strengthen partnerships in the Middle East.
07-30 13:00
加密财库(Crypto Treasury)指的是企业或机构利用闲置或募集资金购买加密货币,并将它们纳入资产负债表,作为储备资产或收益工具。企业纷纷建立加密财库并不是为了乐趣,而是希望通过持有加密货对抗通胀风险,实现资本增值以及提升品牌形象等等。
07-30 12:57